RSS-Feed abonnieren
DOI: 10.1055/s-0029-1241874
© Georg Thieme Verlag KG Stuttgart · New York
Challenges in the Management of Refractory Bilateral Idiopathic Congenital Chylothoraces in a Newborn
Publikationsverlauf
Publikationsdatum:
30. Oktober 2009 (online)
![](https://www.thieme-connect.de/media/ejps/201003/lookinside/thumbnails/10.1055-s-0029-1241874-1.jpg)
Introduction
Chylothorax was first described in 1917 by Pisek and is the most common cause of pleural effusion during the neonatal period. Primary (congenital) chylothorax is rare and often idiopathic; it occurs more commonly in males and is more likely to affect the right side of the chest [20] [23]. There are some known associations of congenital chylothorax such as Down's syndrome, Noonan's syndrome, and Turner's syndrome as well as polyhydraminos and hydrops fetalis [6]. Congenital chylothorax typically presents at birth, or within the first week of life. The presentation is one of respiratory distress and the diagnosis is typically confirmed by chest radiographs and the aspiration of a milky, lymphocyte-rich fluid from the pleural space.
The management of congenital chylothorax typically involves the use of chest drains together with either a low fat, high protein diet supplemented with medium-chain triglycerides, or total parenteral nutrition (TPN). In the majority of cases this management is sufficient to result in resolution of the chylothorax. In some instances however, chylothorax can persist. In these cases various treatment methods have been tried, including the use of the somatostatin analogue (octreotide) and a variety of surgical techniques [8] [17] [27]. Surgical interventions such as pleurodesis, thoracic duct ligation and pleural peritoneal shunts are usually reserved for the most refractory cases with limited success.
In this case report we discuss the evidence base for the management of congenital chylothoraces and describe the successful resolution of refractory bilateral congenital idiopathic chylothorax in a neonate using a combination of bleomycin pleurodesis, surgical pleurodesis and thoracic duct ligation.
References
- 1 Achildi O, Smith BP, Grewal H. Thoracoscopic ligation of the thoracic duct in a child with spontaneous chylothorax. J Laparoendosc Adv Surg Tech A. 2006; 16 546-549
- 2 Ancona A, Suarez de la Torre R, Macotela E. Allergic contact dermatitis from povidone-iodine. Contact Dermatitis. 1985; 13 66-68
- 3 Andersen EA, Hertel J, Pedersen SA. et al . Congenital chylothorax: management by ligature of the thoracic duct. Scand J Thorac Cardiovasc Surg. 1984; 18 193-194
- 4 Aujlaa SJ, Michelsona P, Langmanb CB. et al . Refractory hypercalcemia in an infant secondary to talc pleurodesis resolving after renal transplantation. American Journal of Transplantation. 2008; 8 1329-1333
- 5 Azizkhan RG, Canfield J, Alford BA. et al . Pleuroperitoneal shunts in the management of persistent chylothorax. J Pediatr Surg. 1983; 18 842-850
- 6 Beghetti M, La Scala G, Belli D Bugmann P. et al . Etiology and management of pediatric chylothorax. J Pediatr. 2000; 136 653-658
- 7 Brant A, Eaton T. Serious complications with talc slurry pleurodesis. Respirology. 2001; 6 ((3)) 181-185
- 8 Brissaud O, Desfrere L, Mohsen R. et al . Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal. 2003; 88 531-533
- 9 Chan S, Lau W, Wong W. et al . Chylothorax in children after congenital heart surgery. The Society of Thoracic Surgeons. 2006;
- 10 Cheung YF, Leung MP, Yip MM. Octreotide for the treatment of postoperative chylothorax. J Pediatrics. 2001; 139 157-159
- 11 Engum SA, Rescorla FJ, West KW. et al . The use of pleuroperitoneal shunts in the management of persistent chylothorax in infants. J Pediatr Surg. 1999; 34 286-290
- 12 Liu CS, Chin TW, Wei CF. Successful surgical treatment of bilateral congenital chylothorax: a case report. Zhonghua Yi Xue Za Zhi (Taipei).. 1997; 59 190-193
- 13 Mitanchez D, Walter-Nicolet E, Salomon R. et al . Congenital chylothorax: what is the best strategy?. Arch Dis Child Fetal Neonatal Ed. 2006; 91 ((2)) 153-154
- 14 Mares D, Mathur P. Medical thorascopic talc pleurodesis for chylothorax due to lymphoma: a case series. Chest. 1998; 114 734-735
- 15 Milonakis M, Chatzis AC, Giannopoulos NM. et al . Etiology and management of chylothorax following pediatric heart surgery. J Card Surg. 2009; 24 369-373
- 16 Nakabayashi T, Sagara H, Usukura N. et al . Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomized dogs. Diabetes. 1981; 30 440-445
- 17 Paget-Brown A, Kattwinkel J, Rodgers BM. The use of octreotide to treat congenital chylothorax. J Pediatr Surg. 2006; 41 845-847
- 18 Pandey R, Lee DF. Laparoscopic ligation of the thoracic duct for the treatment of traumatic chylothorax. J Laparoendosc Adv Surg Tech A. 2008; 18 614-615
- 19 Rasiah SV, Lui K. Octreotide in the treatment of congenital chylothorax. J Paediatr Child Health. 2004; 40 585-588
- 20 Rocha G. Pleural effusions in the neonate. Current Opinion in Pulmonary Medicine. 2007; 13 305-311
- 21 Sahin Y, Aydin D. Congenital chylothorax treated with octreotide. Indian Journal of paediatrics. 2007; 72 885-888
- 22 Sieczka EM, Harvey JC. Early thoracic duct ligation for postoperative chylothorax. J Surg Oncol. 1996; 61 56-60
- 23 Straaten H, Gerards L, Krediet T. Chylothorax in the neonatal period. Eur J Pediatr. 1993; 152 2-5
- 24 Tan C, Sedrakyan A, Browne J. et al . The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg. 2006; 29 829-838
- 25 Tansel T, Sayin OA, Ugurlucan M. et al . Successful bleomycin pleurodesis in a patient with prolonged pleural effusion after extracardiac Fontan procedure. Card Surg. 2006; 21 ((6)) 585-586
- 26 Uzner N, Olmez D, Babayigit A. et al . An infant with bilateral congenital idiopathic chylothorax that required thoracic duct liagtion. Turkish Respiratory Journal. 1993; 8 102-104
- 27 Wolff AB, Silen ML, Kokoska. et al . Treatment of refractory chylothorax with externalized pleuroperitoneal shunts in children. Ann Thorac Surg. 1999; 68 1053-1057
- 28 Young S, Dalgleish S, Eccleston A. et al . Severe congenital chylothorax treated with octreotide. Journal of Perinatology. 1999; 24 200-202
Correspondence
Thomas Waterfield
John Radcliffe Hospital Oxford
Paediatric Surgery
Oxford Children's Hospital
OX39DU Oxford
United Kingdom
Telefon: +44/0/234197
Fax: +44/0/1865 234211
eMail: thomas.waterfield@gmail.com